Abstract
Low birth weight has been associated with a higher risk of psychiatric disorders later in life. The underlying causal mechanisms of this relationship are however not clear. In this study, we investigate whether variation in fetal growth has a direct causal effect on mental health. Using birth weight as a proxy measure for fetal growth, we first assessed associations between observed birth weight and later diagnosis of psychiatric disorders in the Danish iPSYCH and ANGI-DK cohorts. Next, we constructed a polygenic score for birth weight based on >1 million variants and tested for association with psychiatric disorders. Finally, using 86 single-nucleotide polymorphisms with robust fetal-only genetic associations with birth weight, we assessed the causal relationship of genetically mediated fetal growth and psychiatric disorders using Mendelian randomization analyses. We found that higher observed birth weight was associated with lower risk of several psychiatric disorders. Polygenic score analyses supported this pattern for attention deficit/hyperactivity disorder, where an increase of one standard deviation in the score for birth weight corresponded to an odds ratio of 0.85 (95% confidence interval 0.79-0.92, P=6.27×10-5). However, one- and two-sample Mendelian randomization analyses did not indicate a direct causal relationship between the birth weight of children and their risk of psychiatric disorders. In conclusion, our study does not support a direct causal effect of fetal growth (as proxied by birth weight) on the risk of psychiatric disorders later in life, suggesting that the observed association between birth weight and mental health is likely to be caused by other factors.
Competing Interest Statement
C.M.B. reports grant support from Lundbeckfonden, author royalties from Pearson, and serves on the stakeholder advisory board of Equip Health Inc. B.J.V. is on the scientific advisory board of Allelica. All other authors have no competing interests to disclose.
Funding Statement
Funding support was received from the Lundbeck Foundation for the Initiative for Integrative Psychiatric Research (iPSYCH). The Anorexia Nervosa Genetics Initiative (ANGI) was an initiative of the Klarman Family Foundation, and additional genotyping was supported by the Lundbeck Foundation (grant no. R276-2018-4581). The Danish National Biobank resource was supported by the Novo Nordisk Foundation. High-performance computer capacity for handling and statistical analysis of iPSYCH data on the GenomeDK HPC facility was provided by the Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing, iSEQ, Aarhus University, Denmark (grant to A.D.B.). The study was partially funded by the A.P. Møller Foundation for the Advancement of Medical Science (L-2022-00301) and the Jascha Foundation (2023-0397) and B.F. was supported by the Novo Nordisk Foundation (NNF17OC0027594).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Danish Scientific Ethics Committee, the Danish Data Protection Agency and the Danish Neonatal Screening Biobank Steering Committee approved iPSYCH2012, iPSYCH2015i and ANGI-DK, combined in the iPSYCH study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study (other than sensitive data) is available upon reasonable request to the authors. Owing to the sensitive nature of the iPSYCH data, individual level data can be accessed only through secure servers where download of individual level information is prohibited. Each scientific project must be approved before initiation, and approval is granted to a specific Danish research institution. International researchers may gain data access through collaboration with a Danish research institution. More information about the iPSYCH project can be obtained at https://ipsych.dk/en/about-ipsych/.
